← Leaderboards
Ramaswamy Krishnan
Beth Israel Deaconess Medical Center
$2,511,520
Attributed
$5,784,271
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,784,271 · 6
By mechanism
R01$4,108,777 · 2
R21$1,675,494 · 4
Top collaborators
- Raymond B. Penn8 shared
- Mark A Birrell4 shared
- Joshua A Boyce4 shared
- Dale D. Tang4 shared
- Rosalyn M Adam1 shared
- Yan Bai1 shared
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungIn VivoRespiratory Smooth MuscleInsightCellsAsthmaBronchoconstrictionMediatingSliceTissuesSafetyMuscle ContractionConstrictionSmooth Muscle MyocytesPharmaceutical PreparationsAsthmaticAgonistSignal TransductionDrug UsageBiological ModelsBaseBronchodilator AgentsIn VitroIn Vivo Model
Grant awards (14)
Harnessing the soluble guanylate cyclase pathway to alleviate early life RSV bronchiolitis$364,484
R21 · FY2025 · AI
Precision-cut bladder slices: an enabling technology for urologic research$337,284
R21 · FY2023 · DK
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction$465,707
R01 · FY2022 · HL
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction$470,086
R01 · FY2021 · HL
Screening for inhibitors of allergen-associated airway smooth muscle contraction$218,750
R21 · FY2021 · AI · contact PI
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2020 · HL
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction$474,337
R01 · FY2020 · HL
Screening for inhibitors of allergen-associated airway smooth muscle contraction$262,500
R21 · FY2020 · AI · contact PI
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2019 · HL
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction$506,463
R01 · FY2019 · HL
Optimizing EP receptor subtype targeting for asthma therapy$537,546
R01 · FY2018 · HL
Optimizing EP receptor subtype targeting for asthma therapy$579,546
R01 · FY2017 · HL
Monitoring contractile forces during airway constriction$276,226
R21 · FY2017 · HL · contact PI
Monitoring contractile forces during airway constriction$216,250
R21 · FY2016 · HL · contact PI